Annual ROA
-13.79%
-26.22%-210.94%
December 1, 2023
Summary
- As of February 6, 2025, CSCI annual return on assets is -13.79%, with the most recent change of -26.22% (-210.94%) on December 1, 2023.
- During the last 3 years, CSCI annual ROA has fallen by -20.44% (-307.37%).
- CSCI annual ROA is now -127.87% below its all-time high of 49.48%, reached on December 1, 2003.
Performance
CSCI ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-31.07%
-13.23%-74.16%
September 1, 2024
Summary
- As of February 6, 2025, CSCI quarterly return on assets is -31.07%, with the most recent change of -13.23% (-74.16%) on September 1, 2024.
- Over the past year, CSCI quarterly ROA has dropped by -17.37% (-126.79%).
- CSCI quarterly ROA is now -136.57% below its all-time high of 84.97%, reached on September 1, 2003.
Performance
CSCI Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
CSCI ROA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -210.9% | -126.8% |
3 y3 years | -307.4% | -126.8% |
5 y5 years | -1109.7% | -126.8% |
CSCI ROA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -210.9% | at low | -271.9% | at low |
5 y | 5-year | -210.9% | at low | -271.9% | at low |
alltime | all time | -127.9% | +95.5% | -136.6% | +91.8% |
COSCIENS Biopharma ROA History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -31.07%(+74.2%) |
Jun 2024 | - | -17.84%(-5.5%) |
Mar 2024 | - | -18.88%(+37.8%) |
Dec 2023 | -13.79%(-210.9%) | -13.70%(+75.2%) |
Sep 2023 | - | -7.82%(+281.5%) |
Jun 2023 | - | -2.05%(-132.1%) |
Mar 2023 | - | 6.38%(-51.4%) |
Dec 2022 | 12.43%(+11.3%) | 13.12%(-27.2%) |
Sep 2022 | - | 18.01%(-0.3%) |
Jun 2022 | - | 18.07%(+19.5%) |
Mar 2022 | - | 15.12%(+35.7%) |
Dec 2021 | 11.17%(+68.0%) | 11.14%(+99.3%) |
Sep 2021 | - | 5.59%(+66.4%) |
Jun 2021 | - | 3.36%(-27.3%) |
Mar 2021 | - | 4.62%(-29.4%) |
Dec 2020 | 6.65%(-251.5%) | 6.54%(-25.9%) |
Sep 2020 | - | 8.82%(+12.6%) |
Jun 2020 | - | 7.83%(+299.5%) |
Mar 2020 | - | 1.96%(-146.1%) |
Dec 2019 | -4.39%(+285.1%) | -4.25%(+37.5%) |
Sep 2019 | - | -3.09%(-19.7%) |
Jun 2019 | - | -3.85%(+63.1%) |
Mar 2019 | - | -2.36%(+110.7%) |
Dec 2018 | -1.14%(-68.8%) | -1.12%(-87.5%) |
Sep 2018 | - | -8.96%(+33.9%) |
Jun 2018 | - | -6.69%(+39.4%) |
Mar 2018 | - | -4.80%(+29.4%) |
Dec 2017 | -3.65%(-121.0%) | -3.71%(-233.0%) |
Sep 2017 | - | 2.79%(-36.4%) |
Jun 2017 | - | 4.39%(-58.2%) |
Mar 2017 | - | 10.51%(-40.6%) |
Dec 2016 | 17.40%(-56.0%) | 17.68%(-54.9%) |
Sep 2016 | - | 39.20%(-22.5%) |
Jun 2016 | - | 50.58%(+0.9%) |
Mar 2016 | - | 50.14%(+13.1%) |
Dec 2015 | 39.55%(+64.2%) | 44.33%(+171.5%) |
Sep 2015 | - | 16.33%(+8.3%) |
Jun 2015 | - | 15.08%(-12.6%) |
Mar 2015 | - | 17.25%(-26.8%) |
Dec 2014 | 24.08%(+533.7%) | 23.56%(-2.1%) |
Sep 2014 | - | 24.06%(+45.6%) |
Jun 2014 | - | 16.53%(-1107.9%) |
Mar 2014 | - | -1.64%(-134.9%) |
Dec 2013 | 3.80%(-128.1%) | 4.70%(+273.0%) |
Sep 2013 | - | 1.26%(-122.0%) |
Jun 2013 | - | -5.73%(+70.5%) |
Mar 2013 | - | -3.36%(-74.8%) |
Dec 2012 | -13.54%(-182.6%) | -13.34%(+958.7%) |
Sep 2012 | - | -1.26%(+240.5%) |
Jun 2012 | - | -0.37%(-105.2%) |
Mar 2012 | - | 7.09%(-61.2%) |
Dec 2011 | 16.39%(-3.4%) | 18.27%(+4.3%) |
Sep 2011 | - | 17.52%(-29.5%) |
Jun 2011 | - | 24.84%(-16.7%) |
Mar 2011 | - | 29.81%(+76.7%) |
Dec 2010 | 16.97% | 16.87%(-246.2%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | -11.54%(-23.2%) |
Jun 2010 | - | -15.02%(+72.2%) |
Mar 2010 | - | -8.72%(+108.6%) |
Dec 2009 | -2.48%(-96.9%) | -4.18%(-71.1%) |
Sep 2009 | - | -14.44%(-50.4%) |
Jun 2009 | - | -29.10%(-59.7%) |
Mar 2009 | - | -72.27%(-12.3%) |
Dec 2008 | -80.66%(+84.0%) | -82.43%(+24.6%) |
Sep 2008 | - | -66.16%(+3.4%) |
Jun 2008 | - | -64.01%(+32.6%) |
Mar 2008 | - | -48.27%(+25.3%) |
Dec 2007 | -43.83%(+261.3%) | -38.53%(+22.9%) |
Sep 2007 | - | -31.34%(+89.6%) |
Jun 2007 | - | -16.53%(+60.8%) |
Mar 2007 | - | -10.28%(-10.5%) |
Dec 2006 | -12.13%(+333.2%) | -11.49%(+692.4%) |
Sep 2006 | - | -1.45%(-44.7%) |
Jun 2006 | - | -2.62%(-221.3%) |
Mar 2006 | - | 2.16%(-170.1%) |
Dec 2005 | -2.80%(-89.9%) | -3.08%(-82.0%) |
Sep 2005 | - | -17.14%(-44.7%) |
Jun 2005 | - | -30.97%(-31.0%) |
Mar 2005 | - | -44.89%(+49.5%) |
Dec 2004 | -27.61%(-155.8%) | -30.02%(-13.8%) |
Sep 2004 | - | -34.82%(-268.9%) |
Jun 2004 | - | 20.61%(-60.2%) |
Mar 2004 | - | 51.76%(+2.8%) |
Dec 2003 | 49.48%(+116.8%) | 50.36%(-40.7%) |
Sep 2003 | - | 84.97%(+38.5%) |
Jun 2003 | - | 61.37%(+34.4%) |
Mar 2003 | - | 45.65%(+99.9%) |
Dec 2002 | 22.82%(-122.6%) | 22.84%(-52.1%) |
Sep 2002 | - | 47.64%(+628.4%) |
Jun 2002 | - | 6.54%(-108.0%) |
Mar 2002 | - | -81.59%(-6.8%) |
Dec 2001 | -100.96%(-67.2%) | -87.52%(-60.6%) |
Sep 2001 | - | -221.86%(+5.2%) |
Jun 2001 | - | -210.81%(+7.4%) |
Mar 2001 | - | -196.21%(-12.7%) |
Dec 2000 | -307.46%(+30.2%) | -224.72%(-8.4%) |
Sep 2000 | - | -245.43%(-3.3%) |
Jun 2000 | - | -253.70%(+14.1%) |
Mar 2000 | - | -222.27%(+15.1%) |
Dec 1999 | -236.23%(+20.5%) | -193.13%(-48.8%) |
Sep 1999 | - | -377.28%(+18.6%) |
Jun 1999 | - | -318.13%(+61.2%) |
Mar 1999 | - | -197.40%(+34.8%) |
Dec 1998 | -196.08%(+61.0%) | -146.44%(+13.8%) |
Sep 1998 | - | -128.66%(+79.0%) |
Jun 1998 | - | -71.86%(+15.8%) |
Mar 1998 | - | -62.04%(+4.2%) |
Dec 1997 | -121.76%(+512.2%) | -59.56%(+274.4%) |
Sep 1997 | - | -15.91%(+56.0%) |
Jun 1997 | - | -10.20%(+131.3%) |
Mar 1997 | - | -4.41% |
Dec 1996 | -19.89% | - |
FAQ
- What is COSCIENS Biopharma annual return on assets?
- What is the all time high annual ROA for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual ROA year-on-year change?
- What is COSCIENS Biopharma quarterly return on assets?
- What is the all time high quarterly ROA for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly ROA year-on-year change?
What is COSCIENS Biopharma annual return on assets?
The current annual ROA of CSCI is -13.79%
What is the all time high annual ROA for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual return on assets is 49.48%
What is COSCIENS Biopharma annual ROA year-on-year change?
Over the past year, CSCI annual return on assets has changed by -26.22% (-210.94%)
What is COSCIENS Biopharma quarterly return on assets?
The current quarterly ROA of CSCI is -31.07%
What is the all time high quarterly ROA for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly return on assets is 84.97%
What is COSCIENS Biopharma quarterly ROA year-on-year change?
Over the past year, CSCI quarterly return on assets has changed by -17.37% (-126.79%)